Phase 2 Eczema Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with atopic dermatitis (a type of eczema) for at least 1 year before the screening visit, based on American Academy of Dermatology guidelines
• People whose eczema severity scores at both the screening and baseline visits are rated at 16 or above on a standard measurement scale called the EASI (Eczema Area and Severity Index)
• People whose skin condition is rated as moderate to severe (a score of 3 or higher) by the examining doctor at both the screening and baseline visits
• People whose eczema affects at least 10% of their body surface area at both the screening and baseline visits
• People whose average weekly itch severity score is 4 or higher (out of 10) at the baseline visit

Who may not be able to join:

• People who have not waited long enough after stopping a previous eczema treatment before entering the trial (confirm with trial site for specific timeframes)
• People who have another condition or health status that could affect how the trial measures the treatment's safety or effectiveness (confirm with trial site)
• People who have significant problems with organ function (confirm with trial site for which organs and what level of dysfunction applies)
• People who are pregnant
• There may be additional exclusion reasons not fully detailed here (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.